Download PDF
CC BY-NC-ND 4.0 · Facial Plast Surg
DOI: 10.1055/a-2305-2007
Original Research

Approaches to the Management of Synkinesis: A Scoping Review

Cédric Zubler 
1   Department of Plastic and Hand Surgery, Inselspital University Hospital Bern, University of Bern, Bern, Switzerland
,
Ankit Punreddy
2   Division of Plastic Surgery, Department of Surgery, University of Rochester Medical Center, Rochester, New York
,
Danielle Mayorga-Young
2   Division of Plastic Surgery, Department of Surgery, University of Rochester Medical Center, Rochester, New York
,
Jonathan Leckenby 
2   Division of Plastic Surgery, Department of Surgery, University of Rochester Medical Center, Rochester, New York
3   Department of Plastic and Reconstructive Surgery, The Great Ormond Street for Sick Children, London, United Kingdom
,
Adriaan O. Grobbelaar
1   Department of Plastic and Hand Surgery, Inselspital University Hospital Bern, University of Bern, Bern, Switzerland
3   Department of Plastic and Reconstructive Surgery, The Great Ormond Street for Sick Children, London, United Kingdom
› Author Affiliations
› Further Information
   Permissions and Reprints

Abstract

Postparalysis facial synkinesis (PPFS) can develop in any facial palsy and is associated with significant functional and psychosocial consequences for affected patients. While the prevention of synkinesis especially after Bell's palsy has been well examined, much less evidence exists regarding the management of patients with already established synkinesis. Therefore, the purpose of this review is to summarize the available literature and to provide an overview of the current therapeutic options for facial palsy patients with established synkinesis. A systematic literature review was undertaken, following the Preferred Reporting Items of Systematic Reviews and Meta-analyses 2020 guidelines. MEDLINE via PubMed and Cochrane Library were searched using the following strategy: ([facial palsy] OR [facial paralysis] OR [facial paresis]) AND (synkinesis) AND ([management] OR [guidelines] OR [treatment]). The initial search yielded 201 articles of which 36 original papers and 2 meta-analyses met the criteria for inclusion. Overall, the included articles provided original outcome data on 1,408 patients. Articles were divided into the following treatment categories: chemodenervation (12 studies, 536 patients), facial therapy (5 studies, 206 patients), surgical (10 studies, 389 patients), and combination therapy (9 studies, 278 patients). Results are analyzed and discussed accordingly. Significant heterogeneity in study population and design, lack of control groups, differences in postoperative follow-up, as well as the use of a variety of subjective and objective assessment tools to quantify synkinesis prevent direct comparison between treatment modalities. To date, there is no consensus on how PPFS is best treated. The lack of comparative studies and standardized outcome reporting hinder our understanding of this complex condition. Until higher quality scientific evidence is available, it remains a challenge best approached in an interdisciplinary team. An individualized multimodal therapeutic concept consisting of facial therapy, chemodenervation, and surgery should be tailored to meet the specific needs of the patient.

Keywords

facial palsy - synkinesis - systematic review - Bell's Palsy


Publication History

Accepted Manuscript online:
11 April 2024

Article published online:
11 May 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Kim SJ, Lee HY. Acute peripheral facial palsy: recent guidelines and a systematic review of the literature. J Korean Med Sci 2020; 35 (30) e245
    CrossrefPubMedGoogle Scholar
  • 2 Montserrat L, Benito M. Facial synkinesis and aberrant regeneration of facial nerve. Adv Neurol 1988; 49: 211-224
    PubMedGoogle Scholar
  • 3 Crumley RL. Mechanisms of synkinesis. Laryngoscope 1979; 89 (11) 1847-1854
    CrossrefPubMedGoogle Scholar
  • 4 Ma ZZ, Lu YC, Wu JJ, Li SS, Ding W, Xu JG. Alteration of spatial patterns at the network-level in facial synkinesis: an independent component and connectome analysis. Ann Transl Med 2021; 9 (03) 240-240
    CrossrefPubMedGoogle Scholar
  • 5 van Veen MM, Quatela O, Tavares-Brito J. et al. Patient-perceived severity of synkinesis reduces quality of life in facial palsy: a cross-sectional analysis in 92 patients. Clin Otolaryngol 2019; 44 (03) 483-486
    CrossrefPubMedGoogle Scholar
  • 6 Walker DT, Hallam MJ, Ni Mhurchadha S, McCabe P, Nduka C. The psychosocial impact of facial palsy: our experience in one hundred and twenty six patients. Clin Otolaryngol 2012; 37 (06) 474-477
    CrossrefPubMedGoogle Scholar
  • 7 Gilden DH. Clinical practice. Bell's Palsy. N Engl J Med 2004; 351 (13) 1323-1331
    CrossrefPubMedGoogle Scholar
  • 8 Katusic SK, Beard CM, Wiederholt WC, Bergstralh EJ, Kurland LT. Incidence, clinical features, and prognosis in Bell's palsy, Rochester, Minnesota, 1968-1982. Ann Neurol 1986; 20 (05) 622-627
    CrossrefPubMedGoogle Scholar
  • 9 Hauser WA, Karnes WE, Annis J, Kurland LT. Incidence and prognosis of Bell's palsy in the population of Rochester, Minnesota. Mayo Clin Proc 1971; 46 (04) 258-264
    PubMedGoogle Scholar
  • 10 Peitersen E. Bell's palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies. Acta Otolaryngol Suppl 2002; 549 (549) 4-30
    CrossrefPubMedGoogle Scholar
  • 11 Adour KK, Byl FM, Hilsinger Jr RL, Kahn ZM, Sheldon MI. The true nature of Bell's palsy: analysis of 1,000 consecutive patients. Laryngoscope 1978; 88 (05) 787-801
    CrossrefPubMedGoogle Scholar
  • 12 Brandenburg NA, Annegers JF. Incidence and risk factors for Bell's palsy in Laredo, Texas: 1974-1982. Neuroepidemiology 1993; 12 (06) 313-325
    CrossrefPubMedGoogle Scholar
  • 13 Campbell KE, Brundage JF. Effects of climate, latitude, and season on the incidence of Bell's palsy in the US Armed Forces, October 1997 to September 1999. Am J Epidemiol 2002; 156 (01) 32-39
    CrossrefPubMedGoogle Scholar
  • 14 Bylund N, Jensson D, Enghag S. et al. Synkinesis in Bell's palsy in a randomised controlled trial. Clin Otolaryngol 2017; 42 (03) 673-680
    CrossrefPubMedGoogle Scholar
  • 15 Beurskens CHG, Oosterhof J, Nijhuis-van der Sanden MWG. Frequency and location of synkineses in patients with peripheral facial nerve paresis. Otol Neurotol 2010; 31 (04) 671-675
    CrossrefPubMedGoogle Scholar
  • 16 Madhok VB, Gagyor I, Daly F. et al. Corticosteroids for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev 2016; 7 (07) CD001942
    PubMedGoogle Scholar
  • 17 Gagyor I, Madhok VB, Daly F, Sullivan F. Antiviral treatment for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev 2019; 9 (09) CD001869
    PubMedGoogle Scholar
  • 18 Menchetti I, McAllister K, Walker D, Donnan PT. Surgical interventions for the early management of Bell's palsy. Cochrane Database Syst Rev 2021; 1 (01) CD007468
    PubMedGoogle Scholar
  • 19 Teixeira LJ, Valbuza JS, Prado GF. Physical therapy for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev 2011; (12) CD006283
    PubMedGoogle Scholar
  • 20 Lapidus JB, Lu JCY, Santosa KB. et al. Too much or too little? A systematic review of postparetic synkinesis treatment. J Plast Reconstr Aesthet Surg 2020; 73 (03) 443-452
    CrossrefPubMedGoogle Scholar
  • 21 Page MJ, McKenzie JE, Bossuyt PM. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372: n71
    CrossrefPubMedGoogle Scholar
  • 22 Coulson SE, Croxson GR, Adams RD, O'Dwyer NJ. Reliability of the “Sydney,” “Sunnybrook,” and “House Brackmann” facial grading systems to assess voluntary movement and synkinesis after facial nerve paralysis. Otolaryngol Head Neck Surg 2005; 132 (04) 543-549
    CrossrefPubMedGoogle Scholar
  • 23 Mehta RP, WernickRobinson M, Hadlock TA. Validation of the Synkinesis Assessment Questionnaire. Laryngoscope 2007; 117 (05) 923-926
    CrossrefPubMedGoogle Scholar
  • 24 Chuang DCC, Chang TNJ, Lu JCY. Postparalysis facial synkinesis: clinical classification and surgical strategies. Plast Reconstr Surg Glob Open 2015; 3 (03) e320
    CrossrefPubMedGoogle Scholar
  • 25 Mountain RE, Murray JAM, Quaba A. Management of facial synkinesis with Clostridium botulinum toxin injection. Clin Otolaryngol Allied Sci 1992; 17 (03) 223-224
    CrossrefPubMedGoogle Scholar
  • 26 Toffola ED, Furini F, Redaelli C, Prestifilippo E, Bejor M. Evaluation and treatment of synkinesis with botulinum toxin following facial nerve palsy. Disabil Rehabil 2010; 32 (17) 1414-1418
    CrossrefPubMedGoogle Scholar
  • 27 Maria CM, Kim J. Individualized management of facial synkinesis based on facial function. Acta Otolaryngol 2017; 137 (09) 1010-1015
    CrossrefPubMedGoogle Scholar
  • 28 Díaz-Aristizabal U, Valdés-Vilches M, Fernández-Ferreras TR. et al. Effect of botulinum toxin type A in functionality, synkinesis and quality of life in peripheral facial palsy sequelae. Neurología (Engl Ed) 2023; 38 (08) 560-565
    CrossrefPubMedGoogle Scholar
  • 29 Filipo R, Spahiu I, Covelli E, Nicastri M, Bertoli GA. Botulinum toxin in the treatment of facial synkinesis and hyperkinesis. Laryngoscope 2012; 122 (02) 266-270
    CrossrefPubMedGoogle Scholar
  • 30 Neville C, Venables V, Aslet M, Nduka C, Kannan R. An objective assessment of botulinum toxin type A injection in the treatment of post-facial palsy synkinesis and hyperkinesis using the synkinesis assessment questionnaire. J Plast Reconstr Aesthet Surg 2017; 70 (11) 1624-1628
    CrossrefPubMedGoogle Scholar
  • 31 Dall'Angelo A, Mandrini S, Sala V. et al. Platysma synkinesis in facial palsy and botulinum toxin type A. Laryngoscope 2014; 124 (11) 2513-2517
    CrossrefPubMedGoogle Scholar
  • 32 Patel PN, Owen SR, Norton CP. et al. Outcomes of buccinator treatment with botulinum toxin in facial synkinesis. JAMA Facial Plast Surg 2018; 20 (03) 196-201
    CrossrefPubMedGoogle Scholar
  • 33 Kanerva M. Buccinator synkinesis treated by botulinum toxin in facial palsy and hemifacial spasms. J Plast Reconstr Aesthet Surg 2021; 74 (07) 1464-1469
    CrossrefPubMedGoogle Scholar
  • 34 Pescarini E, Butler DP, Perusseau-Lambert A, Nduka C, Kannan RY. Targeted chemodenervation of the posterior belly of the digastric muscle for the management of jaw discomfort in facial synkinesis. J Plast Reconstr Aesthet Surg 2021; 74 (12) 3437-3442
    CrossrefPubMedGoogle Scholar
  • 35 Thomas AJ, Larson MO, Braden S, Cannon RB, Ward PD. Effect of 3 commercially available botulinum toxin neuromodulators on facial synkinesis: a randomized clinical trial. JAMA Facial Plast Surg 2018; 20 (02) 141-147
    CrossrefPubMedGoogle Scholar
  • 36 de Jongh FW, Schaeffers AWMA, Kooreman ZE. et al. Botulinum toxin A treatment in facial palsy synkinesis: a systematic review and meta-analysis. Eur Arch Otorhinolaryngol 2023; 280 (04) 1581-1592
    CrossrefPubMedGoogle Scholar
  • 37 Husseman J, Mehta RP. Management of synkinesis. Facial Plast Surg 2008; 24 (02) 242-249
    Article in Thieme ConnectPubMedGoogle Scholar
  • 38 Gil-Martínez A, Lerma-Lara S, Hernando-Jorge A. et al. Influence of mirror therapy (Specular Face Software) on electromyographic behavior of the facial muscles for facial palsy. Brain Sci 2021; 11 (07) 930
    CrossrefPubMedGoogle Scholar
  • 39 Pourmomeny AA, Pourali E, Chitsaz A. Neuromuscular retraining versus BTX-A injection in subjects with chronic facial nerve palsy, a clinical trial. Iran J Otorhinolaryngol 2021; 33 (116) 151-155
    PubMedGoogle Scholar
  • 40 Jeong J, Lee JM, Kim J. Neuromuscular retraining therapy combined with preceding botulinum toxin A injection for chronic facial paralysis. Acta Otolaryngol 2023; 143 (05) 446-451
    CrossrefPubMedGoogle Scholar
  • 41 Azuma T, Nakamura K, Takahashi M. et al. Mirror biofeedback rehabilitation after administration of single-dose botulinum toxin for treatment of facial synkinesis. Otolaryngol Head Neck Surg 2012; 146 (01) 40-45
    CrossrefPubMedGoogle Scholar
  • 42 Lee JM, Choi KH, Lim BW, Kim MW, Kim J. Half-mirror biofeedback exercise in combination with three botulinum toxin A injections for long-lasting treatment of facial sequelae after facial paralysis. J Plast Reconstr Aesthet Surg 2015; 68 (01) 71-78
    CrossrefPubMedGoogle Scholar
  • 43 Mandrini S, Comelli M, Dall'angelo A. et al. Long-term facial improvement after repeated BoNT-A injections and mirror biofeedback exercises for chronic facial synkinesis: a case-series study. Eur J Phys Rehabil Med 2016; 52 (06) 810-818
    PubMedGoogle Scholar
  • 44 Pourmomeny AA, Asadi S, Cheatsaz A. Management of facial synkinesis with a combination of BTX-A and biofeedback: a randomized trial. Iran J Otorhinolaryngol 2015; 27 (83) 409-415
    PubMedGoogle Scholar
  • 45 Monini S, De Carlo A, Biagini M. et al. Combined protocol for treatment of secondary effects from facial nerve palsy. Acta Otolaryngol 2011; 131 (08) 882-886
    CrossrefPubMedGoogle Scholar
  • 46 Micarelli A, Viziano A, Granito I. et al. Combination of in-situ collagen injection and rehabilitative treatment in long-lasting facial nerve palsy: a pilot randomized controlled trial. Eur J Phys Rehabil Med 2021; 57 (03) 366-375
    CrossrefPubMedGoogle Scholar
  • 47 Beurskens CHG, Heymans PG. Physiotherapy in patients with facial nerve paresis: description of outcomes. Am J Otolaryngol 2004; 25 (06) 394-400
    CrossrefPubMedGoogle Scholar
  • 48 Beurskens CHG, Heymans PG. Mime therapy improves facial symmetry in people with long-term facial nerve paresis: a randomised controlled trial. Aust J Physiother 2006; 52 (03) 177-183
    CrossrefPubMedGoogle Scholar
  • 49 Nakano H, Fujiwara T, Tsujimoto Y. et al. Physical therapy for peripheral facial palsy: a systematic review and meta-analysis. Auris Nasus Larynx 2024; 51 (01) 154-160
    CrossrefPubMedGoogle Scholar
  • 50 Fujiwara K, Furuta Y, Yamamoto N, Katoh K, Fukuda S. Factors affecting the effect of physical rehabilitation therapy for synkinesis as a sequela to facial nerve palsy. Auris Nasus Larynx 2018; 45 (04) 732-739
    CrossrefPubMedGoogle Scholar
  • 51 Guerrissi JO. Selective myectomy for postparetic facial synkinesis. Plast Reconstr Surg 1991; 87 (03) 459-466
    CrossrefPubMedGoogle Scholar
  • 52 Yoshioka N. Selective orbicularis neuromyectomy for postparetic periocular synkinesis. J Plast Reconstr Aesthet Surg 2015; 68 (11) 1510-1515
    CrossrefPubMedGoogle Scholar
  • 53 Bran GM, Börjesson PKE, Boahene KD, Gosepath J, Lohuis PJFM. Effect of endoscopic brow lift on contractures and synkinesis of the facial muscles in patients with a regenerated postparalytic facial nerve syndrome. Plast Reconstr Surg 2014; 133 (01) 121-129
    CrossrefPubMedGoogle Scholar
  • 54 Chuang DCC, Chang TNJ, Lu JCY, Zavala A. Surgical treatment for postparalytic facial synkinesis: a 35-year experience. Plast Reconstr Surg 2022; 150 (03) 631-643
    CrossrefPubMedGoogle Scholar
  • 55 Gray ML, Hu S, Gorbea E, Mashkevich G. Masseteric-zygomatic nerve transfer for the management of eye closure-smile excursion synkinesis. Am J Otolaryngol 2020; 41 (04) 102479
    CrossrefPubMedGoogle Scholar
  • 56 Biglioli F, Kutanovaite O, Rabbiosi D. et al. Surgical treatment of synkinesis between smiling and eyelid closure. J Craniomaxillofac Surg 2017; 45 (12) 1996-2001
    CrossrefPubMedGoogle Scholar
  • 57 Terzis JK, Karypidis D. Therapeutic strategies in post-facial paralysis synkinesis in adult patients. Plast Reconstr Surg 2012; 129 (06) 925e-939e
    CrossrefPubMedGoogle Scholar
  • 58 Terzis JK, Karypidis D. Therapeutic strategies in post-facial paralysis synkinesis in pediatric patients. J Plast Reconstr Aesthet Surg 2012; 65 (08) 1009-1018
    CrossrefPubMedGoogle Scholar
  • 59 Azizzadeh B, Irvine LE, Diels J. et al. Modified selective neurectomy for the treatment of post-facial paralysis synkinesis. Plast Reconstr Surg 2019; 143 (05) 1483-1496
    CrossrefPubMedGoogle Scholar
  • 60 Park TH, Park IS, Kim J. How to enhance the success of selective neurectomy for facial synkinesis by considering the patient's preferences: lesson learned from a retrospective analysis of 122 cases. Aesthetic Plast Surg 2023; (e-pub ahead of print). Doi: DOI: 10.1007/S00266-023-03620-8.
    CrossrefPubMedGoogle Scholar
  • 61 van Veen MM, Dusseldorp JR, Hadlock TA. Long-term outcome of selective neurectomy for refractory periocular synkinesis. Laryngoscope 2018; 128 (10) 2291-2295
    CrossrefPubMedGoogle Scholar
  • 62 Lo CKL, Mertz D, Loeb M. Newcastle-Ottawa Scale: comparing reviewers' to authors' assessments. BMC Med Res Methodol 2014; 14 (01) 45
    CrossrefPubMedGoogle Scholar
  • 63 Frueh BR, Felt DP, Wojno TH, Musch DC. Treatment of blepharospasm with botulinum toxin. A preliminary report. Arch Ophthalmol 1984; 102 (10) 1464-1468
    CrossrefPubMedGoogle Scholar
  • 64 Hernández Herrero D, Abdel Muti García E, López Araujo J, Alfonso Barrera E, Moraleda Pérez S. Cost of peripheral facial palsy treatment with Botulinum Toxin type A. J Plast Reconstr Aesthet Surg 2022; 75 (01) 271-277
    CrossrefPubMedGoogle Scholar
  • 65 Neville C, Gwynn T, Young K. et al. Comparative study of multimodal therapy in facial palsy patients. Arch Plast Surg 2022; 49 (05) 633-641
    Article in Thieme ConnectPubMedGoogle Scholar
  • 66 Krag AE, Glick S, Hembd A, Rozen SM. The effect of depressor anguli oris muscle block on facial symmetry in synkinetic facial paralysis patients and its role in preoperative assessment. Plast Reconstr Surg 2021; 147 (03) 455-465
    CrossrefPubMedGoogle Scholar